Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Aug;16(2):149–156. doi: 10.1111/j.1365-2125.1983.tb04979.x

Effects of graded oral doses of meptazinol and pentazocine in comparison with placebo on experimentally induced pain in healthy humans.

G Stacher, H Steinringer, S Winklehner, G Mittelbach, C Schneider
PMCID: PMC1427987  PMID: 6615689

Abstract

The opioid agonist/antagonist meptazinol has proven to exert significant analgesia in a series of painful conditions. This study investigated the effects of single oral doses of meptazinol 100, 200, and 400 mg in comparison with pentazocine 50 and 100 mg and with placebo on experimentally induced pain. In addition, the side effect profiles were assessed. Twenty-four healthy subjects participated each in six experiments in which they received, in random double-blind fashion, each of the treatments. Every experiment comprised 10 series of measurements, two before and eight after drug administration, carried out at 30 min intervals. Meptazinol produced significant dose-related increases of threshold and tolerance to electrically and thermally induced pain. Meptazinol 400 mg was significantly superior to placebo in all pain measures and proved as effective as pentazocine 50 and 100 mg, which yielded about equal effects. Meptazinol 200 mg was significantly weaker than pentazocine 50 mg and differed significantly from placebo only in its effects on pain tolerance. Meptazinol did not cause any severe side effects or systematic alterations of respiration, blood pressure, heart rate and central nervous functions. Pentazocine caused a higher number and more severe side effects, one subject reporting severe dysphoria after pentazocine 100 mg. The results give further evidence that meptazinol is well suited to replace other opioid analgesics compromised by a high incidence of adverse effects.

Full text

PDF
149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Budd K. Meptazinol--a new analgesic effects on hemodynamic stability. Acta Anaesthesiol Belg. 1976;27(3):151–158. [PubMed] [Google Scholar]
  2. Flavell-Matts S. G., Ward P. J. A double blind comparison of meptazinol versus pentazocine in chronic rheumatoid and osteoarthritis. Br J Clin Pract. 1980 Oct;34(10):286–289. [PubMed] [Google Scholar]
  3. Franklin R. A., Aldridge A., White C. B. Preliminary metabolic studies on the new analgesic meptazinol. Br J Clin Pharmacol. 1975 Oct;2(5):472–473. doi: 10.1111/j.1365-2125.1975.tb00560.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gabka J., Price R. K. Tooth pulp stimulation: a method of determining the analgesic efficacy of meptazinol in man. Br J Clin Pharmacol. 1982 Jul;14(1):104–106. doi: 10.1111/j.1365-2125.1982.tb04943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gevins A. S., Zeitlin G. M., Ancoli S., Yeager C. L. Computer rejection of EEG artifact. II. Contamination by drowsiness. Electroencephalogr Clin Neurophysiol. 1977 Jul;43(1):31–42. doi: 10.1016/0013-4694(77)90192-4. [DOI] [PubMed] [Google Scholar]
  6. Hedges A., Rose J., Leighton M., Turner P. A double-blind comparison of meptazinol with placebo in postoperative pain. J Clin Pharmacol. 1977 Feb-Mar;17(2-3):125–127. doi: 10.1002/j.1552-4604.1977.tb04598.x. [DOI] [PubMed] [Google Scholar]
  7. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980 Sep;10(3):189–209. doi: 10.1111/j.1365-2125.1980.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jordan C. Assessment of the effects of drugs on respiration. Br J Anaesth. 1982 Jul;54(7):763–782. doi: 10.1093/bja/54.7.763. [DOI] [PubMed] [Google Scholar]
  9. Lahoda R., Stacher G., Bauer P. Experimentally induced pain: measurement of pain threshold and pain tolerance using a new apparatus for electrical stimulation of the skin. Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):51–56. [PubMed] [Google Scholar]
  10. Paymaster N. J. Clinical assessment of oral meptazinol in postoperative pain. Acta Anaesthesiol Belg. 1976;27(3):159–170. [PubMed] [Google Scholar]
  11. Pearce V., Robson P. J. Double-blind crossover trial of oral meptazinol, pentazocine and placebo in the treatment of pain in the elderly. Postgrad Med J. 1980 Jul;56(657):474–477. doi: 10.1136/pgmj.56.657.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stacher G., Bauer P., Ehn I., Schreiber E. Effects of tolmetin, paracetamol, and of two combinations of tolmetin and paracetamol as compared to placebo on experimentally induced pain. A double blind study. Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):250–255. [PubMed] [Google Scholar]
  13. Stacher G., Bauer P., Schneider C., Winklehner S., Schmierer G. Effects of a combination of oral naproxen sodium and codeine on experimentally induced pain. Eur J Clin Pharmacol. 1982;21(6):485–490. doi: 10.1007/BF00542043. [DOI] [PubMed] [Google Scholar]
  14. Stacher G., Steinringer H., Schmierer G., Winklehner S., Schneider C. Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man. Peptides. 1982 Nov-Dec;3(6):955–962. doi: 10.1016/0196-9781(82)90064-x. [DOI] [PubMed] [Google Scholar]
  15. Staquet M. A double-blind comparison of meptazinol with pentazocine and placebo in cancer pain. J Clin Pharmacol. 1978 Jan;18(1):76–79. doi: 10.1002/j.1552-4604.1978.tb01563.x. [DOI] [PubMed] [Google Scholar]
  16. Stephens R. J., Waterfall J. F., Franklin R. A. A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol. Gen Pharmacol. 1978;9(2):73–78. doi: 10.1016/0306-3623(78)90002-2. [DOI] [PubMed] [Google Scholar]
  17. Wade A. G., Ward P. J. A double-blind comparison of meptazinol versus paracetamol and placebo in acute and chronic painful conditions presented to the general practitioner. Curr Med Res Opin. 1982;8(3):191–196. doi: 10.1185/03007998209112382. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES